Search - tctmd.com

Displaying 181 - 200 of 1337

Sort: Relevancy | Date

Presentation NY Valves 2024

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Helge Möllmann

June 07, 2024

Presentation NY Valves 2024

The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Bassem M. Chehab

June 07, 2024

Presentation NY Valves 2024

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

Presenter: Sebastian Ludwig

June 07, 2024

Presentation NY Valves 2024

The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: John K. Forrest

June 07, 2024

Presentation NY Valves 2024

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

Presenter: Anita W. Asgar

June 07, 2024

Presentation NY Valves 2024

The SAPIEN Balloon-Expandable TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Pradeep K. Yadav

June 07, 2024

Presentation NY Valves 2024

Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk

Presenter: Steven J. Yakubov

June 07, 2024

Presentation NY Valves 2024

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Presenter: Philippe Pibarot

June 07, 2024

Presentation NY Valves 2024

Managing Multi-Valvular Disease and Considerations for Surgical Eligibility

Presenter: Joshua Goldberg

June 07, 2024

Presentation NY Valves 2024

Assessing Functional Status and Predicting Clinical Improvement

Presenter: Suzanne V. Arnold

June 07, 2024

Presentation NY Valves 2024

The Importance of Baseline Hemodynamics and Tricuspid Anatomy

Presenter: Philipp Lurz

June 07, 2024

Presentation NY Valves 2024

Expanding Indications for LAAO to Front Line Therapy for Stroke Reduction in AF: Clinical Trial Updates

Presenter: Shephal K. Doshi

June 06, 2024

Presentation NY Valves 2024

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Presenter: Nicolas M. Van Mieghem

June 06, 2024

News Conference News NY Valves 2024

Long-term Mortality After TAVI Lower With DOACs vs VKAs

Todd Neale

June 06, 2024

Presentation NY Valves 2024

Patient Selection: From Clinical Trials to “On Label” to Real World – Who Are the Right Candidates for LAAO?

Presenter: Samir R. Kapadia

June 06, 2024

Presentation NY Valves 2024

Incidence, Predictors, and Management of Conduction Disturbances After Transcatheter Tricuspid Valve Replacement: The TRIPLACE Registry

Presenter: Andrea Scotti

June 06, 2024

Presentation NY Valves 2024

Surgical Mitral Valve Replacement With a Novel Polymeric Valve: 30-day Results From a Global Clinical Study of the Foldax TRIA Mitral Valve

Presenter: Isaac George

June 06, 2024

Presentation NY Valves 2024

Impact of Tricuspid Regurgitation on Right Heart Remodeling: Insights From the TRILUMINATE Pivotal MRI and CT Imaging Substudy

Presenter: Joao L. Cavalcante

June 06, 2024

Presentation NY Valves 2024

T-TEER in a Broad Range of Anatomies: Results From the TRILUMINATE Pivotal Trial

Presenter: Brian K. Whisenant

June 06, 2024

Presentation NY Valves 2024

The Future of Transcatheter Tricuspid Intervention: What’s Missing in Technology and Clinical Trials?

Presenter: Azeem Latib

June 06, 2024

Advertisement

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

The SAPIEN Balloon-Expandable TAVR Program: Technology Focus and Clinical Trial Priorities

Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Managing Multi-Valvular Disease and Considerations for Surgical Eligibility

Assessing Functional Status and Predicting Clinical Improvement

The Importance of Baseline Hemodynamics and Tricuspid Anatomy

Expanding Indications for LAAO to Front Line Therapy for Stroke Reduction in AF: Clinical Trial Updates

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Long-term Mortality After TAVI Lower With DOACs vs VKAs

Patient Selection: From Clinical Trials to “On Label” to Real World – Who Are the Right Candidates for LAAO?

Incidence, Predictors, and Management of Conduction Disturbances After Transcatheter Tricuspid Valve Replacement: The TRIPLACE Registry

Surgical Mitral Valve Replacement With a Novel Polymeric Valve: 30-day Results From a Global Clinical Study of the Foldax TRIA Mitral Valve

Impact of Tricuspid Regurgitation on Right Heart Remodeling: Insights From the TRILUMINATE Pivotal MRI and CT Imaging Substudy

T-TEER in a Broad Range of Anatomies: Results From the TRILUMINATE Pivotal Trial

The Future of Transcatheter Tricuspid Intervention: What’s Missing in Technology and Clinical Trials?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content